__timestamp | Regeneron Pharmaceuticals, Inc. | Viridian Therapeutics, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 1271353000 | 293000 |
Thursday, January 1, 2015 | 1620577000 | 1002000 |
Friday, January 1, 2016 | 2052295000 | 888000 |
Sunday, January 1, 2017 | 2075142000 | 19623000 |
Monday, January 1, 2018 | 2186100000 | 30421000 |
Tuesday, January 1, 2019 | 3036600000 | 34794000 |
Wednesday, January 1, 2020 | 2735000000 | 28304000 |
Friday, January 1, 2021 | 2908100000 | 56886000 |
Saturday, January 1, 2022 | 3592500000 | 100894000 |
Sunday, January 1, 2023 | 4439000000 | 159765000 |
Monday, January 1, 2024 | 5132000000 |
Igniting the spark of knowledge
In the ever-evolving landscape of biotechnology, research and development (R&D) investments are pivotal. Over the past decade, Regeneron Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. have demonstrated contrasting trajectories in their R&D expenditures. Regeneron, a leader in the field, has consistently increased its R&D spending, culminating in a remarkable 250% growth from 2014 to 2023. This surge underscores their commitment to innovation and maintaining a competitive edge. In contrast, Viridian Therapeutics, while smaller in scale, has shown a significant upward trend, with a staggering 54,000% increase in R&D expenses over the same period. This growth reflects Viridian's strategic focus on expanding its research capabilities. As we look to the future, these investments highlight the dynamic nature of the biotech industry and the relentless pursuit of groundbreaking therapies.
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Insmed Incorporated
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Viatris Inc.
Comparing Innovation Spending: Regeneron Pharmaceuticals, Inc. and Verona Pharma plc
Regeneron Pharmaceuticals, Inc. or Jazz Pharmaceuticals plc: Who Invests More in Innovation?
R&D Insights: How Regeneron Pharmaceuticals, Inc. and PTC Therapeutics, Inc. Allocate Funds
Comparing Innovation Spending: Regeneron Pharmaceuticals, Inc. and Dynavax Technologies Corporation
Cost Management Insights: SG&A Expenses for Regeneron Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.
Analyzing R&D Budgets: Insmed Incorporated vs Viridian Therapeutics, Inc.
Dr. Reddy's Laboratories Limited or Viridian Therapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs Viridian Therapeutics, Inc.
Xencor, Inc. or Viridian Therapeutics, Inc.: Who Invests More in Innovation?